BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11306176)

  • 1. Differential expression of activin/inhibin subunit and activin receptor mRNAs in normal and neoplastic ovarian surface epithelium (OSE).
    Choi KC; Kang SK; Nathwani PS; Cheng KW; Auersperg N; Leung PC
    Mol Cell Endocrinol; 2001 Mar; 174(1-2):99-110. PubMed ID: 11306176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
    Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
    Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The regulation of apoptosis by activin and transforming growth factor-beta in early neoplastic and tumorigenic ovarian surface epithelium.
    Choi KC; Kang SK; Tai CJ; Auersperg N; Leung PC
    J Clin Endocrinol Metab; 2001 May; 86(5):2125-35. PubMed ID: 11344217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presence of activin signal transduction in normal ovarian cells and epithelial ovarian carcinoma.
    Ito I; Minegishi T; Fukuda J; Shinozaki H; Auersperg N; Leung PC
    Br J Cancer; 2000 Apr; 82(8):1415-20. PubMed ID: 10780520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of inhibin/activin subunit messenger ribonucleic acids (mRNAs) by activin A and expression of activin receptor mRNAs in cultured human granulosa-luteal cells.
    Erämaa M; Hildén K; Tuuri T; Ritvos O
    Endocrinology; 1995 Oct; 136(10):4382-9. PubMed ID: 7664658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell survival effect of activin against heat shock stress on OVCAR3.
    Fukuda J; Ito I; Tanaka T; Leung PC
    Life Sci; 1998; 63(25):2209-20. PubMed ID: 9870706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer.
    Kleeff J; Ishiwata T; Friess H; Büchler MW; Korc M
    Int J Cancer; 1998 Sep; 77(6):860-8. PubMed ID: 9714055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
    Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
    Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and secretion of inhibin and activin in normal and neoplastic uterine tissues. High levels of serum activin A in women with endometrial and cervical carcinoma.
    Petraglia F; Florio P; Luisi S; Gallo R; Gadducci A; Viganò P; Di Blasio AM; Genazzani AR; Vale W
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1194-200. PubMed ID: 9543140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in activin receptor, inhibin/activin subunit and follistatin mRNAs in human prostate tumour tissues.
    van Schaik RH; Wierikx CD; Timmerman MA; Oomen MH; van Weerden WM; van der Kwast TH; van Steenbrugge GJ; de Jong FH
    Br J Cancer; 2000 Jan; 82(1):112-7. PubMed ID: 10638976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of inhibin/activin system messenger ribonucleic acids and proteins in ovarian follicles from women with polycystic ovarian syndrome.
    Roberts VJ; Barth S; el-Roeiy A; Yen SS
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1434-9. PubMed ID: 7962340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of activin, inhibin, and follistatin in epithelial ovarian carcinoma.
    Welt CK; Lambert-Messerlian G; Zheng W; Crowley WF; Schneyer AL
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3720-7. PubMed ID: 9360531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of activin A in stage IV colorectal cancer.
    Wildi S; Kleeff J; Maruyama H; Maurer CA; Büchler MW; Korc M
    Gut; 2001 Sep; 49(3):409-17. PubMed ID: 11511564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of inhibin/activin subunit, activin receptor, and follistatin messenger ribonucleic acid in human and mouse oocytes: evidence for activin's paracrine signaling from granulosa cells to oocytes.
    Sidis Y; Fujiwara T; Leykin L; Isaacson K; Toth T; Schneyer AL
    Biol Reprod; 1998 Oct; 59(4):807-12. PubMed ID: 9746729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of gonadal sex cord-stromal tumor cell lines from inhibin-alpha and p53-deficient mice: the role of activin as an autocrine growth factor.
    Shikone T; Matzuk MM; Perlas E; Finegold MJ; Lewis KA; Vale W; Bradley A; Hsueh AJ
    Mol Endocrinol; 1994 Aug; 8(8):983-95. PubMed ID: 7997239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of activin and inhibin subunits, receptors and binding proteins in human adrenocortical neoplasms.
    Hofland J; Timmerman MA; de Herder WW; van Schaik RH; de Krijger RR; de Jong FH
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):792-9. PubMed ID: 17121532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activin regulates betaA-subunit and activin receptor messenger ribonucleic acid and cellular proliferation in activin-responsive testicular tumor cells.
    Di Simone N; Hall HA; Welt C; Schneyer AL
    Endocrinology; 1998 Mar; 139(3):1147-55. PubMed ID: 9492049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A in JEG-3 cells: potential role as an autocrine regulator of steroidogenesis in humans.
    Ni X; Luo S; Minegishi T; Peng C
    Biol Reprod; 2000 May; 62(5):1224-30. PubMed ID: 10775170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and localization of inhibin/activin subunits and activin receptors in MCF-7 cells, a human breast cancer cell line.
    Ying SY; Zhang Z
    Breast Cancer Res Treat; 1996; 37(2):151-60. PubMed ID: 8750582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.